Browse diseases

…rompt capable of ascertaining a patient’s depression from their multiple sclerosis (MS) neurologist’s note and to explore its potential for earlie…

…Background In multiple sclerosis (MS), disability accrual can arise from relapse-associated wors…

…rmed an active demyelinating process. A diagnosis of aggressive multiple sclerosis was established. Immunotherapy with ocrelizumab resulted in cli…

…Background Fatigue is a common symptom of multiple sclerosis (MS) and impacts quality of life, yet the role of chrononutriti…

…rebrovascular diseases and some neurological disorders, such as multiple sclerosis, NMOSD is rare. This case underscores the diagnostic challenge …

…lizumab/rituximab in a real-world cohort of relapsing-remitting multiple sclerosis (RRMS) patients using data from the Middle East and North Afric…

…nd Predicting response to treatment and long-term disability in multiple sclerosis (MS) remains challenging. In other complex diseases, combining …

…e conditions.Conclusion Psychiatric comorbidities are common in MOGAD, particularly depression and anxiety, typically emerging close …

…omplementary therapies (CTs) are widely used among persons with multiple sclerosis (MS). Patients’ expectations of treatment effectiveness are lin…

…e, a potassium channel blocker approved for gait improvement in multiple sclerosis, is being used off-label in ataxia despite limited clinical evi…

…Background and Importance Multiple sclerosis (MS) is a chronic autoimmune disease that causes inflammation a…

…and Methods The patient was a 33-year-old woman, diagnosed with RRMS in 2012. She had previously received several DMTs (interferon b…